73 research outputs found

    Best Practices for Radiographers During the COVID-19 Pandemic

    Get PDF
    Radiographers or Radiological Technologists (RTs) as health professionals are calledupon to stand up to the circumstances and to modify practical applications to dealwith suspected and confirmed cases of Corona Virus Disease 19 (COVID-19). Theyperform chest X-ray examinations and Computed Tomography scans, which are keytools for diagnosing and monitoring patients with Severe Acute Respiratory SyndromeCoronavirus 2 (SARS-CoV-2). They are also an integral part of the departments ofMagnetic Resonance Imaging, Nuclear Medicine, Radiotherapy, Mammography, Orthopantomography- Cephalometric, Bone Density Measurement, and InterventionalRadiology – Hemodynamic. The purpose of this article is to provide RTs guidancethroughout the scope of their work and to keep the Hospital community informed.They are required to fully adhere to personal protective equipment (PPE) practices,such as the use of gloves, high-protection mask, special clothing, eye and feet protection.They should maintain safety distance and come into as little contact as possiblewith the patients. It is necessary to thoroughly disinfect and use protection for all theirwork components, stable or not. There should be separated spaces, in the presencesuspicious and confirmed cases, as well as the rational distribution of staff in theirworkstations and their continuous training and briefing. RTs are present in mediumand high-risk zones. As they are potential virus carriers in hospital units, PPE mustbe applied and strictly monitored. Moreover, workplaces should adapt to the currentprecautionary measures to ensure personal and occupational safety

    Bladder cancer and arsenic through drinking water: A systematic review of epidemiologic evidence

    Get PDF
    Exposure to inorganic arsenic (As) through drinking water is a major international public health issue. We carried out a systematic review of the existing literature examining the association between the risk of bladder cancer in humans and exposure to arsenic through drinking water.We searched electronic databases for studies published from January 2000 up to April 2013. Eight ecological studies, six case-control studies, four cohort studies and two meta-analyses were identified. The vast majority of the studies were carried out in areas with high arsenic concentrations in drinking water such as southwestern and northeastern Taiwan, Pakistan, Bangladesh, Argentina (Cordoba Province), USA (southeastern Michigan, Florida, Idaho) and Chile. Most of the studies reported higher risks of bladder cancer incidence or mortality in areas with high arsenic concentrations in drinking water compared to the general population or a low arsenic exposed control group. The quality assessment showed that among the studies identified, arsenic exposure was assessed at the individual level only in half of them and only three assessed exposure using a biomarker. Further, five out of eight ecological studies presented results with adjustment for potential confounders except for age; all cohort and case-control studies presented results with adjustment for cigarette smoking status in the analysis. The majority of the studies with varying study designs carried out in different areas provided evidence of statistically siginificant increases in bladder cancer risk at high concentrations of arsenic (>50 μg L−1). Assessing bladder cancer risk at lower exposure concentrations requires further investigation

    Ionic Diode Characteristics at a Polymer of Intrinsic Microporosity (PIM) | Nafion “Heterojunction” Deposit on a Microhole Poly(ethylene-terephthalate) Substrate

    Get PDF
    Ionic diode phenomena occur at asymmetric ionomer | aqueous electrolyte microhole interfaces. Depending on the applied potential, either an “open” or a “closed” diode state is observed switching between a high ion flow rate and a low ion flow rate. Physically, the “open” state is associated mainly with conductivity towards the microhole within the ionomer layer and the “closed” state is dominated by restricted diffusion-migration access to the microhole interface opposite to the ionomer. In this report we explore a “heterojunction” based on an asymmetric polymer of intrinsic microporosity (PIM) | Nafion ionomer microhole interface. Improved diode characteristics and current rectification are observed in aqueous NaCl. The effects of creating the PIM | Nafion micro-interface are investigated and suggested to lead to novel sensor architectures

    Cationic diodes by hot-pressing of Fumasep FKS-30 ionomer film onto a microhole in polyethylene terephthalate (PET)

    Get PDF
    A cationic diode is fabricated by hot-pressing a commercial cation-conducting ionomer membrane (Fumasep FKS-30) onto a polyethylene terephthalate (PET) substrate with microhole of 5, 10, 20, or 40 mu m diameter. Both, symmetric (ionomer on both sides) and asymmetric (ionomer only on the working electrode side) cases are investigated in a 4-electrode measurement cell. A 5-electrode measurement cell in generator-collector mode is employed to directly detect competing proton transport through the ionomer. Only the asymmetric device allows ion current rectification to be observed. With decreasing microhole diameter the rectification effect increases. With increasing electrolyte concentration (for aqueous HCl, NaCl, LiCl, NH4Cl, MgCl2, CaCl2) the rectification effect diminishes. Competition between cation transport and proton transport is observed in all cases. A qualitative impedance model is developed to diagnose the quality and performance of these cationic diodes.</p

    Post COVID-19 irritable bowel syndrome

    Get PDF
    Objectives: The long-term consequences of COVID-19 infection on the gastrointestinal tract remain unclear. Here, we aimed to evaluate the prevalence of gastrointestinal symptoms and post-COVID-19 disorders of gut-brain interaction after hospitalisation for SARS-CoV-2 infection. Design: GI-COVID-19 is a prospective, multicentre, controlled study. Patients with and without COVID-19 diagnosis were evaluated on hospital admission and after 1, 6 and 12 months post hospitalisation. Gastrointestinal symptoms, anxiety and depression were assessed using validated questionnaires. Results: The study included 2183 hospitalised patients. The primary analysis included a total of 883 patients (614 patients with COVID-19 and 269 controls) due to the exclusion of patients with pre-existing gastrointestinal symptoms and/or surgery. At enrolment, gastrointestinal symptoms were more frequent among patients with COVID-19 than in the control group (59.3% vs 39.7%, p&lt;0.001). At the 12-month follow-up, constipation and hard stools were significantly more prevalent in controls than in patients with COVID-19 (16% vs 9.6%, p=0.019 and 17.7% vs 10.9%, p=0.011, respectively). Compared with controls, patients with COVID-19 reported higher rates of irritable bowel syndrome (IBS) according to Rome IV criteria: 0.5% versus 3.2%, p=0.045. Factors significantly associated with IBS diagnosis included history of allergies, chronic intake of proton pump inhibitors and presence of dyspnoea. At the 6-month follow-up, the rate of patients with COVID-19 fulfilling the criteria for depression was higher than among controls. Conclusion: Compared with controls, hospitalised patients with COVID-19 had fewer problems of constipation and hard stools at 12 months after acute infection. Patients with COVID-19 had significantly higher rates of IBS than controls. Trial registration number: NCT04691895
    • …